Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial

16 June 2020 : Clinical Research

Wei Yao^1ABE, Lixin Wang^2AB*, Qing Chen^1BC, Fang Wang^1CD, Nana Feng^1EF

DOI: 10.12659/MSM.919977

Med Sci Monit 2020; 26:e919977

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Comparison of ABI and the levels of hs-CRP and IL-in the 2 groups.

		No. of patients	Before the surgery	6 months after the surgery	t	P
hs-CRP, mg·L	ARB group	98	9.60±2.56	3.93±1.43	−9.780	0.001
hs-CRP, mg·L	Control group	96	10.31±3.12	7.27±1.67	−9.780	0.001
IL-6, Ng·L	ARB group	98	26.45±5.23	11.26±2.29	−3.420	0.000
IL-6, Ng·L	Control group	96	27.12±3.12	16.74±1.90	−3.420	0.000
ABI	ARB group	98	0.61±0.59	0.98±0.20	6.230	0.001
ABI	Control group	96	0.58±0.71	0.62±0.48	6.230	0.001

Back to the Article